Radiation Oncologist Dr. Kathy Han is an Associate Professor at University of Toronto, and the Gynecologic Radiation Oncology Site Group Leader at the Princess Margaret Cancer Centre/University Health Network. She completed her MSc in Epidemiology at the Harvard School of Public Health. Her research focuses on MRI-guided adaptive brachytherapy in gynecological cancer and novel, non-invasive biomarkers to personalize cancer treatment. She is the Endometrial Cancer Working Group Co-Chair of the Canadian Cancer Trials Group, and a core member of the NRG cervix committee and the US National Cancer Institute’s Uterine Task Force. Dr. Han is the co-PI of CCTG EN10, a trial evaluating Tailored Adjuvant Therapy in POLE-mutated and p53-wildtype/NSMP Early Stage Endometrial Cancer (TAPER/RAINBO BLUE).
